Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “NITROSAMINES”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,333 records · Page 74Linked to original sources

Nitrosamine formation in bladder infections and its role in the etiology of bladder cancer.

Dimethylnitrosamine, a powerful carcinogen, is produced in the urine of patients with urinary tract infections of Proteus mirabilis and Escherichia coli when nitrite is present. Treatment with tetracycline antibiotics does not enhance the concentration of this carcinogen but, rather, sharply reduces it. The results emphasize the importance of proper antibiotic therapy for the infections to reduce the possibility of the subsequent development of bladder cancer.

Dimethylnitrosamine↗

Radon, tobacco-specific nitrosamine and mutagenesis in mammalian cells.

The mutagenicity of 4-methylnitrosamine-1-3-pyridyl-1-butanone (NNK), either alone or in combination with low dose alpha particle irradiation, was examined using the human-hamster hybrid (A(L)) cell assay. NNK induced a dose-dependent toxicity in A(L) cells. In combination with a 25 cGy dose of alpha particles, the induced survival fraction fell within the statistical range of the calculated values assuming an additive interaction of the two agents. In addition, NNK is mutagenic in A(L) cells at the CD59 locus. Furthermore, a low dose of NNK, when combined with radon alpha particles, resulted in a combined mutagenic effect in A(L) cells that was consistent with an additive model but less than additive at higher NNK concentrations. The majority of NNK induced CD59(-) mutants (77.6%) lost at least one additional marker in addition to the CD59 which encodes the cell surface antigen. When combined with alpha particles, the proportion of mutants with additional marker loss increased with increasing dose of NNK. Our study further confirms that NNK is mutagenic in mammalian cells, induces mostly deletions, and provides an in vitro assessment of the combined genotoxic effects of NNK and alpha particles at low environmentally relevant doses. This finding should be helpful in understanding the molecular mechanism of the mutagenic process as a result of multi-agent interaction.

Alpha Particles↗

Modulation of the mutagenicity and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by phenolic compounds.

NNK is a potent environmental carcinogen generated during tobacco processing and smoking. The carcinogenic response to tobacco smoking is modulated by nutritional factors. In this study, liver microsomes from phenobarbital and beta-naphthoflavone-treated or control hamsters were used to assay the mutagenicity (Salmonella typhimurium TA1535) of NNK. Western analysis of these microsomal preparations revealed an increased expression of protein recognized by polyclonal antibodies specific for P-450 1A2 in beta-naphthoflavone-induced microsomes and P-450 2B1/2B2 in phenobarbital-induced microsomes. Both inducers significantly increased the mutagenicity of NNK. Metabolism of NNK by the three microsomal preparations was compared. Metabolites formed by methyl-hydroxylation of NNK by microsomes from control animals were significantly greater than those formed by alpha-methylene hydroxylation. Phenobarbital treatment had the greatest effect on alpha-methylene hydroxylation while beta-naphthoflavone had the greatest effect on methyl hydroxylation. The antimutagenic action of the polyphenolic compounds ellagic acid, esculetin and propyl gallate correlated with an inhibition of the metabolism of NNK. There were, however, differences in the effects of these compounds on specific pathways of NNK metabolism depending upon the microsomal enzyme induction treatment. This suggests that phenolic compounds have selective affinity for specific P-450 isozymes activating NNK.

Animals↗

N6(Methylnitroso)adenosine: a carcinogenic nitrosamine derived from a naturally-occurring nucleoside.

N6(Methylnitroso) adenosine (M6(NO)Ado) is found readily under acidic conditions by the interaction of nitrite with 6-methyladenosine, a naturally-occurring nucleoside. Swiss mice were treated with M6(NO)Ado by injection (40 mg/kg each treatment) transplacentally and then as newborns and young adults. The incidences of lymphomas, primary lung tumors, and hepatic neoplasms were significantly greater in these treated animals than in controls. These results demonstrate the tumorigenicity of M6(NO)Ado.

Adenosine↗